Roivant Sciences
New York · Founded 2014
About Roivant Sciences
Roivant Sciences is a biopharmaceutical company focused on completing the development of promising late-stage drug candidates. Roivant’s mission is to reduce the time and cost of developing new medicines for patients and to share those savings with the healthcare system. Roivant does this by building Vants - nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying the technology. In addition to its biopharmaceutical subsidiaries, Roivant also builds technology-focused Vants focused on improving the process of developing and commercializing medicines.
Company Facts
- Founded: 2014
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $10K – $50K
- Total funding: $2.5B
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2023)
- Ticker: nasdaq:ROIV
- Website: roivant.com
- Phone: +44 2074003347
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/roivant-sciences-48504 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.